To study the possible role of Cx HCs in dysferlinopathy, we used boldine as a potential therapeutic drug, in dysferlin deficient myoblasts, and in blAJ mice, the animal model of dysferlinopathies [12]. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.